Jump to Content Jump to Main Navigation
HOME BROWSE
CLINICAL RESOURCES DRUG INFORMATION EDUCATION AND TRAINING PHARMACY PRACTICE CAREER DEVELOPMENT
AJHP DRUG INFORMATION PROFESSIONAL DEVELOPMENT
Sign in Sign up
Advanced Search Help
Sign in Sign up
HOME BROWSE
CLINICAL RESOURCES DRUG INFORMATION EDUCATION AND TRAINING PHARMACY PRACTICE CAREER DEVELOPMENT
AJHP DRUG INFORMATION PROFESSIONAL DEVELOPMENT
Advanced Search Help

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients
 

 

  • Front Matter
    Show Items
  • PART I: Elixir/Solution/Suspension/Syrup
    Show Items
  • PART II: Topical/Ophthalmic Solution
    • Bacitracin Ophthalmic Solution 9,600 units/mL
    • Cefazolin Ophthalmic Solution 33 mg/mL
    • Cidofovir Intravitreous Solution 0.2 mg/mL
    • Cidofovir Intravitreous Solution 8.1 mg/mL
    • Fumagillin Ophthalmic Solution 70 mcg/mL
    • Ganciclovir Intravitreous Solution 20 mg/mL
    • Gentamicin Ophthalmic Solution 13.6 mg/mL (Fortified)
    • LET (Lidocaine 4%/Racepinephrine 0.225%/ Tetracaine 0.5%) Topical Solution
    • Tobramycin Ophthalmic Solution 13.6 mg/mL (Fortified)
    • Tobramycin Ophthalmic Solution 15 mg/mL
    • Vancomycin Ophthalmic Solution 31 mg/mL
    • Voriconazole Ophthalmic Solution 1 mg/mL
    • Voriconazole Ophthalmic Solution 10 mg/mL
  • PART III: Commercially Available Products
    Show Items
  • Back Matter
    Show Items

Tobramycin Ophthalmic Solution 13.6 mg/mL (Fortified)

in Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients
Editors:
Rita K. Jew
,
Winson Soo-Hoo
,
Sarah C. Erush
, and
Elham Amiri
DOI:
https://doi.org/10.37573/9781585285259.144
Restricted access
Email this content

Share Link


Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully

About ASHP Contact Us Correction Notices Customer Relations
FAQs Information for Authors Libraries and Institutions Rights and Permissions

© 2023 American Society of Health-System Pharmacists. All Rights Reserved.

Powered by: PubFactory

Powered by PubFactory
  • [3.238.250.73]
  • 3.238.250.73
Close
Edit

Character limit 500/500

@!

Character limit 500/500